Arkolith/Insider Trading/VIVO/Form 4

Sazdanoff Catherine

DirectorMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Jan 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
1 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2023Disposed to issuer(D)16K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2023Disposed to issuer(D)17K$23.54$405K0
Jan 31, 2023Disposed to issuer(D)12K$21.20$254K0
Jan 31, 2023Disposed to issuer(D)9K$15.36$131K0
Jan 31, 2023Disposed to issuer(D)9K$15.82$134K0
Jan 31, 2023Disposed to issuer(D)6K$13.25$75K0
Jan 31, 2023Disposed to issuer(D)6K$12.64$73K0
Jan 31, 2023Disposed to issuer(D)9K$17.03$149K0
Jan 31, 2023Disposed to issuer(D)12K$17.80$214K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-001536) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML